Loading clinical trials...
Loading clinical trials...
The ACUITY Trial: A Randomized Comparison of Angiomax (Bivalirudin) Versus Heparin (Unfractionated Heparin or Enoxaparin) in Patients Undergoing Early Invasive Management for Acute Coronary Syndromes Without ST-Segment Elevation
Conditions
Interventions
Angiomax (bivalirudin) anticoagulant
Locations
1
United States
Cardiovascular Research Foundation
New York, New York, United States
Start Date
August 1, 2003
Completion Date
January 1, 2007
Last Updated
August 21, 2007
NCT07478003
NCT07142265
NCT06939738
NCT05168462
NCT04528511
NCT04973397
Lead Sponsor
The Medicines Company
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions